Sirtex wants medical professionals and patients to understand how SIR-Spheres® Y-90 resin microspheres can help improve clinical outcomes and the quality of life for people with liver cancer. To help achieve this objective, we want to provide medical journalists and health writers with balanced and comprehensive information about our company, our technology and the medical needs we address.


Latest News

24 Apr 2017
SIR-Spheres® Y-90 resin microspheres Substantially Improves Quality of Survival in Primary Liver Cancer, New Study against Standard Treatment Shows
Read More
12 Dec 2016
NCCN Guidelines® Recommend SIR-Spheres® Y-90 Resin Microspheres for the Treatment of Metastatic Colorectal Cancer
Read More
21 Nov 2016
ELPA Calls on Patients with Primary Liver Cancer (HCC) to Share their Experiences in First Global Survey
Read More
More News



Now leaving sirtex.com

You are about to leave the Sirtex Web site. This link is provided to you as a service and will take you to a site maintained by a third party who is solely responsible for the content.

Please be aware that Sirtex takes no responsibility for content of these external sites, nor do we endorse, warrant or guarantee the products, services or information described or offered on other internet sites.

Click 'Continue' to proceed to the third-party Web site.

Continue

×

You are now leaving your current sirtex.com region

The Sirtex site you are linking to is intended only for healthcare practitioners and patients outside your current region. Any products discussed herein may have different approved product labeling; therefore, any information provided may not be appropriate for use in your region.

Click 'Continue' to proceed to the other Sirtex region Web site.

Continue

×

This content is intended for journalists only

By clicking "Yes" you are confirming that you are a journalist. If you are not a journalist, then please click "Go to Homepage" which will direct you to the Sirtex homepage.

Yes Go to Homepage